Blair Lawrence Naughty

Blair Lawrence Naughty discloses dealings in Med BioGene Inc. to SEDI. The record holds 8 filings, for trades running from 15 April 2019 to 17 February 2021.

Market trades split into 4 purchases (€3,058) and 3 sales (€45k). The net balance comes to €42k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2021 to date brings no purchases and 3 sales.

Half of the purchases are above €557 and half below. The 4 purchases reviewed show no overlap with other insiders buying the same stock within a month.

The newest entry dates from 18 February 2021: an open-market sale of €27k, in Med BioGene Inc. The most recent open-market purchase was published on 24 September 2019, 2,588 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 8 days. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.